Accumulating evidence suggests that Nrf2 is expressed at low levels in the brain tissue of patients with AD [7, 8] and that Nrf2 activation can reduce several pathological features of AD in mice [9]. This evidence concerns the gene NFE2L2 and Alzheimer disease.